Global Pathology Board Comparison · 2026

FRCPath vs ABPath vs NEET SS —
The World's Major Pathology Board Exams, Compared

Q: How much does each exam cost?

FRCPath Part 1: ~£1,000 per sitting. ABPath AP-only: $2,100. ABPath AP/CP: $2,600. NEET SS: ₹4,720 (~$57) for general category.

Q: Is the FRCPath exam format changing?

Yes. RCPath confirmed that Autumn 2026 is the last sitting in the current format. A new format begins Spring 2027.

Q: Does NEET SS have a pass rate?

NEET SS is a ranking exam, not pass/fail. Candidates are ranked by percentile and seats allocated based on rank, category, and available positions.

Q: Does eLearningFRCPath cover all three exams?

Our content is built on WHO 5th Edition and CAP guidelines, covering the organ-system pathology shared across all three exams. We explicitly support FRCPath and NEET SS and align with ~95% of the ABPath AP blueprint. We don't offer ABPath CME credits.

A side-by-side comparison of the three most important pathology certification exams globally: FRCPath (UK, Royal College of Pathologists), ABPath AP (US, American Board of Pathology), and NEET SS Pathology (India, NBEMS). All data verified from official exam body sources.

🇬🇧 FRCPath · UK 🇺🇸 ABPath AP · US 🇮🇳 NEET SS · India

Complete Side-by-Side Comparison

Every data point sourced from official exam body publications. Scroll right on mobile.

Feature	FRCPath Part 1 (UK)	ABPath AP (US)	NEET SS Pathology (India)
Exam Body	Royal College of Pathologists (RCPath)	American Board of Pathology (ABPath)	National Board of Examinations (NBEMS)
What It Certifies	Foundational pathology knowledge for Fellowship; gateway to Part 2 and eventual CCT	Board certification in Anatomic Pathology; required for independent practice in US	Entry to DM/DrNB super-specialty seats (Oncopathology, Hematopathology, Nephropathology)
Exam Format	Single paper: EMQs, SBAs, BOFs (varies by specialty). Online, invigilated centres	One-day, computer-based: Written/Practical (205 Qs, 3h 25m) + Virtual Microscopy (90 Qs, 4h 30m). Pearson VUE centres	Computer-based: 150 MCQs in 3 sections of 50 Qs × 50 minutes each. Exam centres across India
Total Questions	~125 (varies by specialty)	~295 (205 written + 90 VM)	150 MCQs
Total Duration	~3 hours (varies)	~8 hours (two sessions)	2.5 hours (3 × 50 min sections)
Question Style	EMQs, SBAs, Best-of-Five. Some image-based	Single-best-answer MCQs + Virtual Microscopy with annotated digital slides	Single-best-answer MCQs. ~30–40% image-based
Negative Marking	No	No	No (as of recent years; confirm in official bulletin)
Content Focus	Core theoretical knowledge in chosen pathology specialty. UK guidelines (NICE, RCPath datasets)	~95% organ-system pathology (surgical path, cytopathology, hematopath, molecular). ~5% lab management	~40% feeder specialty (MD Pathology), ~60% super-specialty (Oncopathology). WHO classifications, molecular pathology
Standards Referenced	WHO 5th Edition, RCPath guidelines, NICE guidelines, UK clinical practice	WHO 5th Edition, CAP guidelines, AJCC staging, ACGME competencies	WHO 5th Edition, CAP guidelines (India follows CAP), AJCC staging, NCCN guidelines
Eligibility	Registered in recognised pathology training programme (UK ST-level or international equivalent). Educational supervisor sign-off required	Completed ACGME-accredited residency (36 months AP-only or 48 months AP/CP). Full US/Canadian medical licence required	MD/DNB Pathology or equivalent. No upper age limit. Open to all nationalities with qualifying degree
Training Required	Variable by specialty. Histopathology typically ST2+ in UK training pathway	36 months (AP-only) or 48 months (AP/CP) ACGME-accredited training. Minimum 18 months structured AP	MD Pathology or equivalent completed. No minimum years beyond qualifying degree
Exam Frequency	Twice yearly: Spring and Autumn	Twice yearly: Spring (May–Jun) and Fall (Oct)	Once yearly (typically Nov–Mar period)
2026 Exam Dates	Spring: 23 Mar–1 May 2026. Results: 22 May 2026. Autumn: TBC	Spring: May 11–Jun 6, 2026. Fall: Oct 5–19, 2026	NEET SS 2026 (for 2026-27 session): expected Jan–Mar 2027. Confirm at natboard.edu.in
Exam Fee	~£1,000 per sitting	$2,100 (AP-only) or $2,600 (combined AP/CP)	₹4,720 (General) / ₹3,540 (SC/ST/PwD) — approximately $55–57
Pass Rate	~70% overall (Spring 2025). Histopathology: 67%. Published by RCPath	Not routinely published by ABPath. Research suggests upward trend over past decade. Criterion-referenced (not curved)	Not published as a percentage. Percentile-based ranking system. Cut-off varies by specialty and category
Scoring Method	Psychometric standard-setting. Pass/fail outcome. Detailed performance letter provided	Criterion-referenced testing (CRT). Pass/fail. Cut-off set in advance by expert committee	Percentile-based ranking. No absolute pass/fail — candidates ranked against each other for seat allocation
Maximum Attempts	4 attempts. Further attempts require Mitigating Circumstances Panel approval	No published maximum. Must reapply each session	No limit on attempts
Result Delivery	Emailed to candidates (Part 1). Results by midday UK time on scheduled date	Released ~6 weeks after exam window closes. Via ABPath PATHway portal	Published on natboard.edu.in. Typically within 15–20 days of exam
Career Outcome	Progression to Part 2 → Fellowship (FRCPath) → CCT → Consultant position in NHS/international	Board certification → Independent practice → Hospital privileges → Subspecialty fellowship eligibility	DM/DrNB admission → Super-specialty training → Senior consultant/academic positions in India
International Recognition	UK, Ireland, Gulf states, parts of Africa, Australasia. Pathway to GMC registration	US and Canada primarily. Recognised globally as a benchmark of pathology competence	India primarily. Not directly recognised abroad, but DM qualification valued internationally
Exam Centres	UK and expanding international centres (online, invigilated)	Pearson VUE centres across US. Limited international availability	Multiple centres across India

Sources: RCPath Examinations, ABPath Primary Certification, ABPath Fees, ABPath Blueprint, NBEMS. All data verified as of May 2026.

The 90%+ Syllabus Overlap — Why One Preparation Covers All Three

The same pathology, the same standards, different exam formats.

90%+

Organ-system pathology overlap across FRCPath, ABPath AP, and NEET SS

All three exams test surgical pathology, IHC, molecular markers, and tumour classification based on WHO 5th Edition

This is the insight that most candidates miss. The three exams feel different — different countries, different formats, different institutions — but the core knowledge tested is nearly identical. Here's why:

Shared knowledge foundations

WHO Classification of Tumours, 5th Edition — all three exams use the same tumour classification system, the same grading criteria, and the same molecular markers. When you study pancreatic neoplasms for FRCPath, you're studying the same PanIN-IPMN-MCN-SPN taxonomy that ABPath and NEET SS test.
CAP (College of American Pathologists) guidelines — CAP protocols define synoptic reporting, biomarker testing standards (HER2, PD-L1, MMR), and quality assurance requirements. India follows CAP guidelines. RCPath datasets align with the same principles. ABPath tests CAP protocols directly.
Immunohistochemistry panels — CK7/CK20, TTF-1, PAX8, GATA3, CDX2, p40, p63, CD markers for lymphoma — the same IHC panels are tested everywhere because diagnostic pathology is a global discipline.
Molecular pathology — EGFR, ALK, ROS1, BRAF, KRAS, NTRK, HER2, MMR/MSI — these predictive and prognostic biomarkers are tested across all three exams because they drive treatment decisions worldwide.

What differs between the exams

Format: FRCPath uses EMQs/SBAs. ABPath uses SBAs with virtual microscopy. NEET SS uses SBA MCQs with image-based questions. The question format changes; the knowledge doesn't.
Country-specific guidelines: FRCPath tests UK-specific guidelines (NICE, RCPath datasets). ABPath references CAP protocols and ACGME competencies. NEET SS may reference Indian clinical practice. These account for approximately 5–10% of content variation.
Lab management: ABPath devotes ~5% to lab management and informatics. FRCPath includes clinical governance. NEET SS has minimal lab management content. This is the one area of genuine non-overlap.
Exam purpose: FRCPath Part 1 is a progression exam (gateway to Part 2). ABPath AP is a certification exam (required for independent practice). NEET SS is a ranking exam (for super-specialty seat allocation).

What this means for your preparation: If you're studying organ-system pathology, IHC, molecular markers, and WHO classifications — you're preparing for all three exams simultaneously. The only additions are format-specific practice (EMQs for FRCPath, VM for ABPath, timed sections for NEET SS) and country-specific guidelines.

Which Exam Should You Take?

Depends on where you want to practise and what stage of training you're in.

Take FRCPath if you want to:

Practise as a consultant pathologist in the UK (NHS or private)
Obtain GMC registration through a qualification route (avoiding PLAB)
Work in the Gulf states (UAE, Saudi Arabia, Qatar) where FRCPath is widely recognised
Gain an internationally respected credential alongside your Indian or other national qualification
Eventually obtain Fellowship (FRCP) and CCT in the UK

Explore FRCPath Part 1 preparation →

Take ABPath AP if you want to:

Practise pathology in the United States (board certification is effectively mandatory)
Obtain hospital privileges and CLIA laboratory director status
Pursue subspecialty fellowships in the US (dermatopathology, neuropathology, etc.)
Meet ACGME milestones and complete US residency requirements

Explore Anatomic Pathology board review resources →

Take NEET SS if you want to:

Gain a DM or DrNB super-specialty degree in India
Specialise in Oncopathology, Hematopathology, or Nephropathology
Pursue academic or senior consultant positions in Indian medical colleges
Strengthen your profile for international opportunities (FRCPath, research fellowships)

Explore NEET SS Pathology 2026 preparation →

For international medical graduates (IMGs) deciding between pathways

If you're an IMG — particularly from India, Pakistan, Egypt, or Nigeria — you may be weighing FRCPath against ABPath or considering both. Here's the practical reality:

FRCPath is accessible to IMGs without completing a UK residency — you can sit the exam internationally and use it for GMC registration. It's the most accessible global pathway for practising pathologists.
ABPath requires completing an ACGME-accredited residency in the US/Canada. If you haven't done US residency, you cannot sit the ABPath exam — but you can still prepare the knowledge using AP-aligned resources.
NEET SS is open to all MD Pathology graduates regardless of nationality and has no attempt limit.
Preparing for one strengthens readiness for all. A candidate who studies organ-system pathology, WHO 5th Edition, IHC, and molecular markers using a structured platform is building knowledge that transfers directly to any of these exams.

One Platform. Three Exams. Same Pathology.

Built on WHO 5th Edition and CAP guidelines — the shared foundation of FRCPath, ABPath AP, and NEET SS.

Our courses, MCQs, and notes are designed so that one thorough preparation covers the organ-system pathology, IHC, and molecular markers tested across all three exams. Whether you're targeting one exam or multiple, the knowledge base is the same.

Explore Full Course → AP Board Review Free Board Questions Free 199 MCQ PDF

Frequently Asked Questions

Can I prepare for FRCPath and ABPath simultaneously?

Yes. Since both exams test organ-system pathology based on WHO 5th Edition and CAP-aligned standards, preparing for one builds readiness for the other. The main differences are exam format (FRCPath uses EMQs/SBAs; ABPath uses SBA with virtual microscopy) and country-specific guidelines. If you're studying surgical pathology, IHC, and molecular markers systematically, you're covering both exams.

Is FRCPath harder than ABPath?

They test different things in different formats. FRCPath Part 1 has a published overall pass rate of ~70% (Spring 2025). ABPath doesn't routinely publish pass rates, but research in the Archives of Pathology & Laboratory Medicine indicates an upward trend over the past decade. FRCPath is a progression exam within a training pathway; ABPath is a certification exam after completing residency. Direct difficulty comparison isn't meaningful because the exams serve different purposes in different training systems.

Can I sit ABPath without US residency training?

No. ABPath requires completion of ACGME-accredited residency training (36 months for AP-only, 48 months for AP/CP). You must also hold a full US or Canadian medical licence. If you haven't completed US residency, you cannot sit the ABPath certification exam — but you can still study AP-aligned content to strengthen your organ-system pathology knowledge for other exams or future US training.

How much does each exam cost?

FRCPath Part 1: approximately £1,000 (~$1,250) per sitting. ABPath AP-only: $2,100. ABPath combined AP/CP: $2,600. NEET SS: ₹4,720 (~$57) for general category. The cost difference is significant — NEET SS is by far the most affordable, while ABPath is the most expensive.

Which exam is recognised in the Gulf states (UAE, Saudi Arabia, Qatar)?

FRCPath is the most widely recognised pathology qualification in the Gulf. It's accepted by licensing bodies in the UAE (DHA, DOH, MOHAP), Saudi Arabia (Saudi Commission for Health Specialties), Qatar (QCHP), and Oman. ABPath is also recognised but less commonly held by pathologists in the region. NEET SS and Indian DM qualifications may require additional licensing steps.

Is the FRCPath exam format changing?

Yes. RCPath has confirmed that the Autumn 2026 sitting will be the last in the current examination format, with a new format commencing from Spring 2027. If you're planning to sit under the current format, Autumn 2026 is your final opportunity. Check the RCPath website for details on the new format.

Does NEET SS have a pass rate?

NEET SS doesn't have a pass rate in the traditional sense because it's a ranking exam, not a pass/fail exam. Candidates are ranked by percentile, and seats are allocated based on rank, category, and available positions. The "cut-off" varies each year depending on the candidate pool and available DM/DrNB seats.

What is the ABPath virtual microscopy component?

The ABPath AP exam includes a Virtual Microscopy (VM) section with approximately 90 questions over 4.5 hours. Candidates view digitised glass slides on screen and answer diagnostic questions. There are no physical glass slides. This section tests pattern recognition, diagnostic accuracy, and the ability to navigate digital pathology — skills increasingly important in modern practice.

Can preparing for NEET SS help with FRCPath Part 1?

Yes — significantly. The syllabus overlap between NEET SS Oncopathology and FRCPath Part 1 Histopathology is approximately 85–90%. Both exams test surgical pathology across all organ systems, WHO classifications, IHC markers, and molecular pathology. Many candidates on our platform prepare for both exams simultaneously. The main addition for FRCPath is UK-specific guidelines (NICE, RCPath datasets) and the EMQ format.

Does eLearningFRCPath cover all three exams?

Our platform's content — 800+ MCQs, system-by-system notes, 200+ hours of video lectures, and mock tests — is built on WHO 5th Edition and CAP guidelines, covering the organ-system pathology that is shared across all three exams. We explicitly support FRCPath Part 1 and NEET SS preparation, and our content aligns with approximately 95% of the ABPath AP exam blueprint. We do not offer ABPath-specific CME credits or lab management content.

Sources & Disclaimer

Disclaimer: eLearningFRCPath is not affiliated with, endorsed by, or officially associated with the American Board of Pathology (ABPath), the Royal College of Pathologists (RCPath), or the National Board of Examinations (NBEMS). All exam details on this page are sourced from official publications of these organisations. Always verify exam information directly from the relevant exam body before making decisions.